Stay updated on Roxadustat in End-Stage Renal Disease Clinical Trial
Sign up to get notified when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.

Latest updates to the Roxadustat in End-Stage Renal Disease Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check38 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study objectives and criteria related to the efficacy and safety of roxadustat for end-stage renal disease, while adding new collaborators and a revision update.SummaryDifference18%
- Check45 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check89 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check103 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to Roxadustat in End-Stage Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.